Generative Data Intelligence

Psychedelics

The ketamine conundrum – moving K to class A won’t change a thing

Special K. Ket. Wonkey Donkey. Ketamine is a widely used clinical and veterinary anaesthetic that has been used as a party drug in the...

Top News

Course: Diversity, Culture and Social Justice in Psychedelics 2025

January 6th – March 24th 2025, 10:30am-12pm PST/1:30pm-3pm EST REGISTER HERE Price $700 USD Price $320 for CE creditsCE Credits Offered: 16 total Scholarship Application This course is a partnership...

PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious...

Toronto, Ontario–(Newsfile Corp. – October 31, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused...

(Re)imagining Healing: Lessons from Indigenous Wisdom

The Illusion of Self-Improvement Have you ever considered that your constant preoccupation with self-improvement, personal healing, and addressing childhood trauma might actually be the cause...

Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant

NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that the Company has...

Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for...

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of naturally derived psilocybin-based...

Santo Daime and Its Impact on Child Development

The psychedelic renaissance has arrived in the US with the legalization of some types of psychedelics in a number of states. Despite this growing...

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

SARASOTA, FL, Sept. 10, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on...

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors

NEW YORK and MELBOURNE, Australia, Sept. 10, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (the “Company” or “Incannex”), a clinical-stage biopharmaceutical company developing...

Revitalist Lifestyle and Wellness Ltd. Partners with Wake Network to Launch Lion’s Brain Supplements for Enhanced Mental Clarity and Wellbeing

Vancouver, British Columbia–(Newsfile Corp. – September 5, 2024) – Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO), a leading mental health...

Special Issue on Diversity, equity, and access in psychedelic medicine

Journal of Psychedelic Studies, 2020 Guest Editors: Monnica T. Williams (University of Ottawa) and Bia Labate (Chacruna Institute) Monnica T. Williams is a board-certified licensed clinical psychologist and...

Recent articles

spot_img